v3.26.1
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Segment Net Loss, Including Disaggregated Components of Operating Expenses

The Company's consolidated and segment net loss, including disaggregated components of operating expenses is as follows (in thousands):

 

 

 

 

 

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

 

 

 

 

 

 

 

2026

 

 

2025

 

2026

 

 

2025

 

Collaboration revenue

 

 

 

 

 

 

 

$

773

 

 

$

937

 

$

1,807

 

 

$

1,503

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Verekitug program:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asthma indication

 

 

 

 

 

 

 

 

12,943

 

 

 

13,236

 

 

23,653

 

 

 

23,257

 

COPD indication

 

 

 

 

 

 

 

 

8,348

 

 

 

6,803

 

 

19,310

 

 

 

12,490

 

CRSwNP indication

 

 

 

 

 

 

 

 

2,000

 

 

 

2,238

 

 

3,089

 

 

 

5,001

 

Personnel expenses

 

 

 

 

 

 

 

 

6,876

 

 

 

4,509

 

 

14,077

 

 

 

8,214

 

Manufacturing costs

 

 

 

 

 

 

 

 

4,065

 

 

 

10,000

 

 

9,038

 

 

 

12,129

 

Professional fees and other

 

 

 

 

 

 

 

 

1,857

 

 

 

1,079

 

 

3,487

 

 

 

2,571

 

Total research and development expenses

 

 

 

 

 

 

 

 

36,089

 

 

 

37,865

 

 

72,654

 

 

 

63,662

 

General and administrative:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Personnel expenses

 

 

 

 

 

 

 

 

4,328

 

 

 

3,773

 

 

9,265

 

 

 

8,005

 

Professional fees

 

 

 

 

 

 

 

 

1,538

 

 

 

2,397

 

 

3,572

 

 

 

3,893

 

Other

 

 

 

 

 

 

 

 

1,186

 

 

 

1,249

 

 

2,299

 

 

 

2,303

 

Total general and administrative expenses

 

 

 

 

 

 

 

 

7,052

 

 

 

7,419

 

 

15,136

 

 

 

14,201

 

Total operating expenses

 

 

 

 

 

 

 

 

43,141

 

 

 

45,284

 

 

87,790

 

 

 

77,863

 

Loss from operations

 

 

 

 

 

 

 

 

(42,368

)

 

 

(44,347

)

 

(85,983

)

 

 

(76,360

)

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

 

 

 

 

 

 

2,659

 

 

 

4,431

 

 

5,713

 

 

 

9,174

 

Other income (expense), net

 

 

 

 

 

 

 

 

7

 

 

 

(50

)

 

(23

)

 

 

(50

)

Total other income, net

 

 

 

 

 

 

 

 

2,666

 

 

 

4,381

 

 

5,690

 

 

 

9,124

 

Segment and consolidated net loss

 

 

 

 

 

 

 

$

(39,702

)

 

$

(39,966

)

$

(80,293

)

 

$

(67,236

)